Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.73 -0.07 (-1.30%)
As of: Oct 22, 2026 · 10:23 AM EDT

Orchestra BioMed Holdings (OBIO) Convertible Debt (2026)

Updated

Orchestra BioMed Holdings' Convertible Debt was $20.44 million in Q2 2026.

Analysis

Orchestra BioMed Holdings (OBIO) Convertible Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 252.57 Bn 231.60 Bn 4.88 Bn
2 Abbott Laboratories 176.08 Bn 146.51 Bn 7.27 Bn
3 Danaher 163.92 Bn 147.72 Bn 3.61 Bn
4 Intuitive Surgical 155.68 Bn 135.10 Bn 1.96 Bn
5 Medtronic 121.40 Bn 86.65 Bn 6.34 Bn
6 Stryker 117.11 Bn 103.23 Bn 4.50 Bn
7 Boston Scientific 66.70 Bn 61.47 Bn 3.85 Bn
8 Becton Dickinson 54.26 Bn 51.41 Bn 2.32 Bn
9 Edwards Lifesciences 51.46 Bn 35.46 Bn 1.35 Bn
10 Orchestra BioMed Holdings 365.64 Mn -41.05 Mn 63,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.44 Mn
API Access

Orchestra BioMed Holdings Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=OBIO&period=max&api_key=YOUR_API_KEY